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Abstract: This paper addresses the problem of mathematical deconvolution for the estimation
of unknown inputs in linear discrete-time state-space models. We apply our deconvolution
algorithm to the modeling of blood glucose (BG) concentration for people with type 1 diabetes
(T1D). We present a method using an activity tracking watch, a continuous glucose monitor
and an insulin pump to study the effect of physical activity on BG concentration for people
with T1D. The physical activity signatures are represented by an unknown input, also referred
to as a ”net effect”. In addition, the net effect captures the unmodelled BG variations, eg.
mismatches in meal estimation, and circadian metabolic variations. We test our method using
data from a clinical study. We show the glucose net effect traces associated to physical activity
for a specific patient during 20 consecutive days, and the glucose net effect traces associated to
physical activity for eight subjects under identical conditions. The net effect signatures can be
used to (i) reproduce experiments with different insulin administration strategies, (ii) build a
physiological model of glucose-insulin dynamics able to simulate a physical activity in people
with T1D, and (iii) design a model-based control algorithm able to predict the effect of physical
activity on the blood glucose concentration.
Keywords: Type 1 diabetes, Physical activity, Deconvolution, Disturbance estimation, Net
effect.
1. INTRODUCTION
In people with type 1 diabetes (T1D), physical activity,
and more generally a healthy lifestyle, is an essential
complement to insulin therapy. It is recommended that
patients with T1D undertake more physical activity than
non-diabetic patients (Chimen et al. (2012)). Among other
benefits, a regular physical activity improves blood glucose
(BG) regulation in T1D, and reduces postprandial glucose
excursions (Manohar et al. (2012)). However, the fear of
hypoglycemia is the main barrier to the practice of a regu-
lar physical activity in T1D (Brazeau et al. (2008)), which
may lead to prolonged hyperglycemia during and after
physical activity. Therefore, it is hypothesized that being
able to predict the effects of exercise on BG concentration
may improve metabolic control and encourage the regular
practice of physical activity.
From a control perspective, BG regulation during and
after physical activity still remains a challenge (Breton
(2008); Riddell et al. (2015)). Among other effects, phys-
ical activity results in an increased glucose uptake from
the muscles, an increased glucose endogenous production,
 This paper is funded by The Danish Diabetes Academy supported
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a decreased insulin resistance, and a faster mobilization of
subcutaneously administered insulin (Basu et al. (2014)).
The glucose response to an exercise are highly dependent
on the patient and the exercise intensity. While mild
and moderate exercise usually require a decrease in basal
insulin requirements and carbohydrates intake, intensive
exercise may in some cases require a temporary increase
in insulin basal rate to mitigate the increased endogenous
glucose production from the liver (Turner et al. (2016)).
A number of models of T1D and simulators are available,
for example Dalla Man et al. (2014); Wilinska and Hovorka
(2014). Attempts have been made to model the effect of
physical activity in T1D (Dalla Man et al. (2009); Duun-
Henriksen et al. (2013); Schiavon (2014)). Nevertheless, no
consensus exists yet as to the model form or parametriza-
tion necessary to encompass the variety of responses ob-
served in clinical practices.
Accelerometers coupled with heart rate signal can detect
physical activity and its intensity (Lazaro et al. (2016)),
and the most recent devices able to track the physical
activity may be sufficiently reliable to be used in clinical
practice (Case et al. (2015)). For example, Breton et al.
(2014) have shown that the integration of these devices
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serv d in clinical practices.
Accelerometers coupled with heart rate signal can detect
physical activity and its intensity (Lazaro et al. (2016)),
and the most recent devices able to track the physical
activity may be sufficiently reliable to be used in clinical
practice (Case et al. (2015)). For example, Breton et al.
(2014) have shown that the integration of these devices
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1. INTRODUCTION
I people with type 1 diabetes (T1D), physical activity,
and mor generally a health lifestyl , is an essenti l
complemen to ins lin therapy. It is recommended t t
patients with T1D undertake more physical activity than
no -diabetic patients (Chimen et al. (2012)). Amon other
benefits, a regular physical activity im roves blood
(BG) regulation in T1D, nd reduces p stprandial glucose
excursions (Mano ar et al. (2012)). However, the fear of
hypoglycemia is the main barrier to the practice of a regu-
lar physical activity in T1D (Brazeau et al. (2008)), which
may lead to prolonged hyperglycemia during and after
physical act vity. Therefore, it is hyp thesized tha be ng
able to edict the effe ts of exercise on BG concentration
m y improve met bolic control and encourage the regular
practice of physical activity.
From a control perspec ve, BG regulation during and
after physical ac ivity still remains a c all nge (Breton
(2008); R ddell et al. (2015)). Among other effects, phys-
ical activity results in an in reas d glucose u take fr m
the muscles, an increased glucose endogenous production,
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a decre s d insulin res ance, and a faster mobi ization of
subcutaneously administered insulin (Basu et al. (2014)).
The glucose respo se o an exercise ar highly dep ndent
o the patient and the exercise ntensity. While mild
and moderate exercise usually require a decrease in basal
insulin requirements and ca bohydr tes intake, intensiv
exercise may in some cases requir a temporary increase
in insulin basal rate t mitigate the incr ased endogenous
glucose production from the liver (Turner et al. (2016)).
A number of models of T1D and simulators are available,
for example Dalla Man et al. (2014); Wilinska and Hovorka
(2014). Attempts have been made to model the effect of
physical activity in T1D (D lla Man et al. (2009); Duu -
Henrik en t al. (2013); Schiavon (2014)). Neverthel ss, no
consensus exists y t as to the model form or parametriza
tion necessary to encompass the variety of responses ob-
served in clinical practices.
Accelerome ers coupled with heart rate signal can detect
physical activity and its intensity (Lazaro et al. (2016)),
nd the most recent devices able to track the phys
activity may be sufficiently reliabl to be used in clinical
practice (Case et al. (2015)). For example, Breton et al.
(2014) have shown that the integration of these devices
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1. INTRODUCTION
In people with type 1 diabetes (T1D), physical activity,
and more generally a healthy lifestyle, is an essential
complement to insulin therapy. It is recommended that
patients with T1D undertake more physical activity than
non-diabetic patients (Chimen et al. (2012)). Among other
benefits, a regular physical activity improves blood glucose
(BG) regulation in T1D, and reduces postprandial glucose
excursions (Manohar et al. (2012)). However, the fear of
hypoglycemia is the main barrier to the practice of a regu-
lar physical activity in T1D (Brazeau et al. (2008)), which
may lead to prolonged hyperglycemia during and after
physical activity. Therefore, it is hypothesized that being
able to predict the effects of exercise on BG concentration
may improve metabolic control and encourage the regular
practice of physical activity.
From a control perspective, BG regulation during and
after physical activity still remains a challenge (Breton
(2008); Riddell et al. (2015)). Among other effects, phys-
ical activity results in an increased glucose uptake from
the muscles, an increased glucose endogenous production,
 This paper is funded by The Danish Diabetes Academy supported
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a decreased insulin resistance, and a faster mobilization of
subcutaneously administered insulin (Basu et al. (2014)).
The glucose response to an exercise are highly dependent
on the patient and the exercise intensity. While mild
and moderate exercise usually require a decrease in basal
insulin requirements and carbohydrates intake, intensive
exercise may in some cases require a temporary increase
in insulin basal rate to mitigate the increased endogenous
glucose production from the liver (Turner et al. (2016)).
A number of models of T1D and simulators are available,
for example Dalla Man et al. (2014); Wilinska and Hovorka
(2014). Attempts have been made to model the effect of
physical activity in T1D (Dalla Man et al. (2009); Duun-
Henriksen et al. (2013); Schiavon (2014)). Nevertheless, no
consensus exists yet as to the model form or parametriza-
tion necessary to encompass the variety of responses ob-
served in clinical practices.
Accelerometers coupled with heart rate signal can detect
physical activity and its intensity (Lazaro et al. (2016)),
and the most recent devices able to track the physical
activity may be sufficiently reliable to be used in clinical
practice (Case et al. (2015)). For example, Breton et al.
(2014) have shown that the integration of these devices
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into a closed-loop system (artificial pancreas) reduces the
risk of hypoglycemia during and after an exercise in clinical
studies.
The ”net effect” is a technique that refers to deconvolution
and can be used to estimate unmeasured disturbances
(Prasath and Jørgensen (2009)). Del Favero et al. (2014)
used deconvolution techniques to improve the accuracy
of continuous glucose monitors (CGM) after calibration.
Patek et al. (2016) used net effect to characterize the
impact of CHO intake. Vettoretti et al. (2016) established
that net effect can be used to some extent to replay
simulations. However, the problem of deconvolution is
usually an ill-posed problem, since several solutions can
be found. One of the ways to circumvent this problem is
to use regularization.
In this paper, we use the net effect to quantify the impact
of physical activity on BG concentrations for patients
with T1D. Periods of physical activity are identified by
using an activity tracking watch. The use of net effect to
collect BG variations caused by physical activity serves
three purposes: (i) To recreate the clinical experiments
under different conditions, (ii) to recreate physical activity
in silico, and (iii) to design exercise-informed closed-loop
algorithms.
Fig. 1 describes the procedure developed in this paper.
A CGM measures the glucose concentration; a connected
watch evaluates the level of physical activity (idle, mild,
moderate or intensive); a CSII pump provides the history
of insulin infusions; and the subject estimates the meal
size. These data are provided to a discrete-time linear
mathematical model and are used to identify the model
parameters. The glucose net effect is determined as the
solution of a convex quadratic program (QP).
The paper is structured as follows. Section 2 states and
discusses the problem of deconvolution for linear time-
invariant state space models. Section 3 describes the clin-
ical protocol used to collect the insulin, glucose and phys-
ical activity data. In Section 4, we present the method
for estimating a discrete-time linear model of the glucose-
insulin dynamics and to compute the net effect. Section
5 presents and discusses the results on the clinical study
data. Section 6 summarizes the main contributions of this
paper.
2. PROBLEM FORMULATION
In this section, we state and discuss the model involved in
deconvolution. We consider the discrete-time state space
model
xk+1 = Axk +Buuk +Bwwk, (1a)
zk = Cxk, (1b)
yk = zk + vk, (1c)
where xk is the state vector. uk is a vector representing
the supposedly known input. zk is the controlled variable.
yk is the measured output, and may be noise corrupted.
vk ∼ Niid(0, R) is a white noise process. Here, we assume
that A, B, Bw and C are known. The deconvolution
problem considered in this paper consists in estimating
the unknown input vector (also referred to as an unknown
disturbance or as a net effect), wk. The problem of de-
Model identification 
and deconvolution
PA 
net effect
signatures
Processed
CGM signal
s.c. insulin
injection
Physical
activity (PA)
CHO in
meals
Glucose
residuals
Mathematical model of
patient physiology
Fig. 1. Principle of net effect. Information about CGM
measurements, sc. insulin, physical activity and meals
are used to compute the net effect signatures associ-
ated to physical activity.
convolution is usually an ill-posed problem, and therefore
requires the addition of a regularization term.
Remark 1. In this work, we made the choice to put the
unknown disturbance on the state vector, xk. The main
reason behind this choice is that this disturbance should
model an unknown glucose rate of appearance/disappear-
ance. Alternatively, this term may be applied to the output
vector, ie.
yk = Cxk + vk + wk. (2)
Remark 2. The state space model (1) can also be derived
from numerous models, such as a continuous-time transfer
function model, a Box-Jenkins model, an ARX/ARMAX
model, a stochastic differential equation (SDE) model, or
a step/impulse response model.
2.1 Net effect estimation
The net effect, wk = w(tk), is determined as a solution
of a convex quadratic program. We consider the following
optimization problem
min
ek,wk
φ =
∑
‖vk‖22 + λ1‖wk‖1 + λ2‖∆wk‖22, (3a)
s.t. (1). (3b)
λ1‖wk‖1 and λ2‖∆wk‖22 are regularization terms. The
weight on the 1-norm of wk, λ1, penalizes non-sparse net
effects, and is sometimes referred to as the least abso-
lute shrinkage and selection operator (lasso) regression
described eg. in Tibshirani (1996). The weight on the
2-norm of ∆wk, λ2, ensures small variations on the net
effect vector.
By introducing the slack variables, sk, we can reformulate
the optimization problem (3) as the constrained convex
quadratic program
min
vk,wk,sk
∑
‖vk‖22 + λ1sk + λ2‖∆wk‖22 (4a)
s.t. (1), (4b)
− sk ≤ wk ≤ sk, (4c)
sk ≥ 0. (4d)
IFAC BMS 2018
São Paulo, Brazil, September 3-5, 2018
271
272 Dimitri Boiroux  et al. / IFAC PapersOnLine 51-27 (2018) 270–275
The term λ1sk in (4a) and the inequality constraints
(4c-4d) give the two cases for the optimal value of the
slack variables sk{
sk = wk if wk ≥ 0,
sk = −wk if wk < 0. (5)
Consequently, the numerical solution of (4) yields the net
effect wk.
3. COLLECTION OF CLINICAL DATA
Data were collected during an IRB-approved clinical trial
NCT02558491 (http://www.clinicaltrials.gov) at the Uni-
versity of Virginia from 15 study subjects on CSII and
10 study subjects on multiple daily injections (MDI), ie.
insulin pen, all having been diagnosed with type 1 diabetes
for at least six months. Each patient experienced two
identical outpatient admissions of 48 hours (separated by
four weeks or more), experiencing both meal and exercise
challenges designed to induce glucose variability. Each sub-
ject was randomized into experiencing either ”usual care”
first or optimized individualized decision support. Decision
support parameters were computed from ”open-loop” data
including CGM (blinded if not already a CGM user),
insulin delivery, meals (with carbohydrate estimates), and
physical activity. In addition to CGM data, meal and
insulin data were collected.
4. NET EFFECT
A number of unknown factors may affect BG concentra-
tions in T1D, including (i) variability in insulin sensitivity,
caused by eg. stress, illness, menstrual cycles, physical
activity, (ii) variations in insulin transport after physical
activity, (iii) under- or overestimating the CHO content of
a meal (Brazeau et al. (2013)), (iv) the difference in meal
dynamics, related for instance to the fat content of the
meal.
In this section, we present our net effect algorithm to
capture the effect of these sources of uncertainty, and
in particular physical activity on BG concentration. This
net effect will capture the variations in glucose utilization
during physical activity that matches the CGM and insulin
administration data.
We use an extended version of the minimal model of
glucose-insulin dynamics published in Bergman et al.
(1979), referred to as the subcutaneous oral glucose min-
imal model (SOGMM). The SOGMM model is presented
in Patek et al. (2016). This model includes the effect of
subcutaneously administered insulin, CHO intakes, and a
term that describes the effect of factors such as physical
activity and model-patient mismatches. The continuous-
time model is individualized using the patient’s body
weight and two identified parameters, namely the insulin
gain and one time constant.
We linearize the continuous-time model of CHO absorp-
tion and convert it into a discrete-time transfer function
model. Similarly, we use a second-order linear transfer
function model to describe the effect of subcutaneous
insulin infusion on BG concentration. Using these transfer
function models, we compute the glucose net effect as the
solution of a constrained optimization problem.
4.1 Mathematical model
In the SOGMM model, the BG concentration, G(t)
[mg/dL], is given by
G˙(t) = −
(
1
τG
+X(t)
)
G(t) +
Gb
τG
+
Ra(t)
Vg
+ w(t), (6)
in which τG [min] is a time constant associated to glu-
cose. w(t) [mg/dL/min] is an additional input to BG
concentration (the net effect). Gb [mg/dL] is the basal BG
concentration. X(t) [1/min] is the proportion of insulin in
the remote compartment.
4.2 Continuous-time transfer function models
The full continuous-time model of glucose dynamics ex-
pressed in the Laplace domain is
G(s) = H1(s)Ω(s) +H2(s)UI(s)
+H3(s)W (s) +H4(s)E(s).
(7)
The following continuous-time transfer function model de-
scribes the dynamics between the Laplace transforms of
the ingested CHO, Ω(s), and the blood glucose concentra-
tion, G(s)
H1(s) =
G(s)
Ω(s)
=
KG
(τCHOs+ 1)
2
(τGs+ 1)
. (8)
The time constants, τCHO and τG, are fixed to 40 and 100
minutes, respectively (Hovorka et al. (2004); Patek et al.
(2016)). The gain, KG, is (Patek et al. (2016))
KG =
f
BWVG
. (9)
f represents the bioavailability of CHO. VG is the glucose
distribution volume. The patient’s body weight, BW ,
is individualized for each patient. Table 1 summarizes
the numerical values of the fixed parameters used for
identification. The transfer function model (8) would be
similar to a linearization of the glucose compartment and
the meal compartments.
We propose here a second-order transfer function model,
H2(s) from subcutaneously administered insulin to blood
glucose
H2(s) =
KI
(τIs+ 1)
2 , (10)
in which the insulin gain, KI , and the time constant, τI ,
are identified. Although this transfer function model is of
a lower order than the linearization of the SOGMM, we
showed in our previous work that this second order model
structure offered the best trade-off between identifiability
and closed-loop performance (Boiroux et al. (2015); Hag-
drup et al. (2016)).
We also consider a transfer function model of blood glucose
H3(s) =
G(s)
W (s)
=
τG
τGs+ 1
. (11)
This transfer function describes all the dynamics that are
not modelled by the transfer functions (8) and (10). It
includes the metabolic variations in insulin sensitivity, the
mismatches in meal and insulin dynamics, inaccuracies
in carbohydrate counting, physical activity etc. The term
W (s) is not known in the Laplace domain, but is estimated
in its discrete-time form, as shown in Section 2.1.
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The term λ1sk in (4a) and the inequality constraints
(4c-4d) give the two cases for the optimal value of the
slack variables sk{
sk = wk if wk ≥ 0,
sk = −wk if wk < 0. (5)
Consequently, the numerical solution of (4) yields the net
effect wk.
3. COLLECTION OF CLINICAL DATA
Data were collected during an IRB-approved clinical trial
NCT02558491 (http://www.clinicaltrials.gov) at the Uni-
versity of Virginia from 15 study subjects on CSII and
10 study subjects on multiple daily injections (MDI), ie.
insulin pen, all having been diagnosed with type 1 diabetes
for at least six months. Each patient experienced two
identical outpatient admissions of 48 hours (separated by
four weeks or more), experiencing both meal and exercise
challenges designed to induce glucose variability. Each sub-
ject was randomized into experiencing either ”usual care”
first or optimized individualized decision support. Decision
support parameters were computed from ”open-loop” data
including CGM (blinded if not already a CGM user),
insulin delivery, meals (with carbohydrate estimates), and
physical activity. In addition to CGM data, meal and
insulin data were collected.
4. NET EFFECT
A number of unknown factors may affect BG concentra-
tions in T1D, including (i) variability in insulin sensitivity,
caused by eg. stress, illness, menstrual cycles, physical
activity, (ii) variations in insulin transport after physical
activity, (iii) under- or overestimating the CHO content of
a meal (Brazeau et al. (2013)), (iv) the difference in meal
dynamics, related for instance to the fat content of the
meal.
In this section, we present our net effect algorithm to
capture the effect of these sources of uncertainty, and
in particular physical activity on BG concentration. This
net effect will capture the variations in glucose utilization
during physical activity that matches the CGM and insulin
administration data.
We use an extended version of the minimal model of
glucose-insulin dynamics published in Bergman et al.
(1979), referred to as the subcutaneous oral glucose min-
imal model (SOGMM). The SOGMM model is presented
in Patek et al. (2016). This model includes the effect of
subcutaneously administered insulin, CHO intakes, and a
term that describes the effect of factors such as physical
activity and model-patient mismatches. The continuous-
time model is individualized using the patient’s body
weight and two identified parameters, namely the insulin
gain and one time constant.
We linearize the continuous-time model of CHO absorp-
tion and convert it into a discrete-time transfer function
model. Similarly, we use a second-order linear transfer
function model to describe the effect of subcutaneous
insulin infusion on BG concentration. Using these transfer
function models, we compute the glucose net effect as the
solution of a constrained optimization problem.
4.1 Mathematical model
In the SOGMM model, the BG concentration, G(t)
[mg/dL], is given by
G˙(t) = −
(
1
τG
+X(t)
)
G(t) +
Gb
τG
+
Ra(t)
Vg
+ w(t), (6)
in which τG [min] is a time constant associated to glu-
cose. w(t) [mg/dL/min] is an additional input to BG
concentration (the net effect). Gb [mg/dL] is the basal BG
concentration. X(t) [1/min] is the proportion of insulin in
the remote compartment.
4.2 Continuous-time transfer function models
The full continuous-time model of glucose dynamics ex-
pressed in the Laplace domain is
G(s) = H1(s)Ω(s) +H2(s)UI(s)
+H3(s)W (s) +H4(s)E(s).
(7)
The following continuous-time transfer function model de-
scribes the dynamics between the Laplace transforms of
the ingested CHO, Ω(s), and the blood glucose concentra-
tion, G(s)
H1(s) =
G(s)
Ω(s)
=
KG
(τCHOs+ 1)
2
(τGs+ 1)
. (8)
The time constants, τCHO and τG, are fixed to 40 and 100
minutes, respectively (Hovorka et al. (2004); Patek et al.
(2016)). The gain, KG, is (Patek et al. (2016))
KG =
f
BWVG
. (9)
f represents the bioavailability of CHO. VG is the glucose
distribution volume. The patient’s body weight, BW ,
is individualized for each patient. Table 1 summarizes
the numerical values of the fixed parameters used for
identification. The transfer function model (8) would be
similar to a linearization of the glucose compartment and
the meal compartments.
We propose here a second-order transfer function model,
H2(s) from subcutaneously administered insulin to blood
glucose
H2(s) =
KI
(τIs+ 1)
2 , (10)
in which the insulin gain, KI , and the time constant, τI ,
are identified. Although this transfer function model is of
a lower order than the linearization of the SOGMM, we
showed in our previous work that this second order model
structure offered the best trade-off between identifiability
and closed-loop performance (Boiroux et al. (2015); Hag-
drup et al. (2016)).
We also consider a transfer function model of blood glucose
H3(s) =
G(s)
W (s)
=
τG
τGs+ 1
. (11)
This transfer function describes all the dynamics that are
not modelled by the transfer functions (8) and (10). It
includes the metabolic variations in insulin sensitivity, the
mismatches in meal and insulin dynamics, inaccuracies
in carbohydrate counting, physical activity etc. The term
W (s) is not known in the Laplace domain, but is estimated
in its discrete-time form, as shown in Section 2.1.
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Table 1. Numerical values of the fixed param-
eters.
Parameter Unit Value
f - 1
τG min 100
τCHO min 40
VG dL/kg 1.6
We consider a stochastic term in the transfer function
model of blood glucose, which is
H4(s) =
G(s)
E(s)
. (12)
This transfer function includes all the other glucose varia-
tions.
4.3 Discrete-time linear model
We discretize the continuous-time model (7) into discrete-
time Box-Jenkins model using a zero-order hold (ZOH)
parametrization on the inputs. The resulting discrete-time
Box-Jenkins model is
y(tk) =
B1(q
−1)
A1(q−1)
uI(tk) +
B2(q
−1)
A2(q−1)
uM (tk)
+
B3(q
−1)
A3(q−1)
w(tk) + e(tk).
(13)
The sampling time is 5 minutes. A1(q
−1), A2(q−1),
A3(q
−1), B1(q−1), B2(q−1) and B3(q−1) are polynomi-
als of appropriate orders. w(tk) [mg/dL/min] describes
the effect of physical activity and other unmodelled phe-
nomenons on blood glucose concentration. e(tk) is assumed
to be a white noise process. The discrete-time Box-Jenkins
model (13) can be realized as a multiple input single out-
put autoregressive moving average with exogenous inputs
(ARMAX) model
A¯(q−1)y(tk) = B¯(q−1)U(tk) + C¯(q−1)e(tk), (14)
in which U(tk) represents the three inputs, ie. the insulin
injections, uI(tk), the meal intakes, uM (tk), and the net
effect, w(tk). It is defined as
U(tk) =
[
uI(tk)
uM (tk)
w(tk)
]
. (15)
The polynomials A¯(q−1), B¯(q−1) and C¯(q−1) are
A¯(q−1) = A1(q−1)A2(q−1)A3(q−1), (16a)
B¯(q−1) =
B1(q−1)A2(q−1)A3(q−1)A1(q−1)B2(q−1)A3(q−1)
A1(q
−1)A2(q−1)B3(q−1)
T , (16b)
C¯(q−1) = A1(q−1)A2(q−1)A3(q−1). (16c)
4.4 Parameter identification
We use a least squares to identify the deterministic model
of glucose-insulin dynamics
G(s) = H1(s)Ω(s) +H2(s)UI(s). (17)
We identify the gains, KI and KG, and the time constant
associated to sc. insulin absorption, τI . The deterministic
part of (13)
Gd(tk) =
B1(q
−1)
A(q−1)
uI(tk) +
B2(q
−1)
A(q−1)
uM (tk) (18)
describes the effects of the insulin infusion rate, uI(tk),
and the ingested meals, uM (tk), on the BG concentration,
G(tk).
The discrete-time transfer functions, B1(q
−1)/A(q−1) and
B2(q
−1)/A(q−1), are obtained by discretization of the
continuous-time transfer functions H1(s) and H2(s) in
(17), respectively.
4.5 State space realization
The ARMAX model (14) may be represented as a discrete-
time state space model in innovation form
xk+1 = Axk +BIuI,k +BMuM,k +Bwwk +Kek, (19a)
yk = Cxk + vk, (19b)
where xk is the state vector. uI,k, uM,k and wk are
the insulin injections, the meal intake and the net effect,
respectively. vk ∼ Niid(0, R) is a white noise process. The
innovation, ek, is
ek = yk − yˆk|k−1. (20)
We realize the state space model (19) such that the
matrices A, BI , BM , Bw and K are in observer canonical
form (Boiroux et al. (2012)).
5. RESULTS AND DISCUSSION
In this section, we present net effect signals for the eight
subjects undergoing the same physical activity under the
same experimental conditions, and show net effect traces
for a specific subject having a regular physical activity
over a 20-day period. For each subject, we compute the
net effect signal as described in section 4 and isolate
the timings of physical activity by using the information
provided by the activity tracker. The physical activity time
is defined when the subject is either ”moderately active”
or ”very active” according to the activity tracking watch.
Fig. 2 shows the reconstructed CGM data using the
discrete-time linear model (13) and the net effect blood
glucose variations computed as the solution of (4) for a
period of 24 hours. The figure shows that this formulation
is able to correctly reconstruct the CGM signal by using a
linear physiological model of glucose-insulin dynamics and
a net effect term capturing the variations in blood glucose
that are not included in the linear model.
5.1 Inter-patient variability
Fig. 3 shows the mean and standard deviation of the
glucose after the beginning of a physical exercise. We
extracted the net effect signatures associated to the stan-
dardized physical activity included in the control outpa-
tient admission (no use of the decision support system).
The time, duration and intensity are identical for the 8
considered subjects. The figure shows that the variability
in the net effect values is high for the considered subjects
at the beginning of the physical activity. In some cases,
intensive physical activity may increase BG concentration.
This increase in BG concentration may be caused by an
increase in endogenous glucose production from the liver,
or by the absorption of a snack before the exercise onset.
The maximum glucose uptake happens approximately 20
to 30 minutes after the beginning of the physical activity.
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Fig. 2. Example of reconstruction of the CGM signal using
the model (14).
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Fig. 3. Net effect signatures associated to physical activity
for the 8 subjects during the control period.
5.2 Net effect signatures for a specific subject
Fig. 4 illustrates the processed glucose concentration trace
measured by a CGM, exercise times and the glucose net
effect for a period of 36 hours. Other variations in net effect
can be due to intra-patient metabolic variations, CGM
noise or longer-term effects of physical activity.
Fig. 5 shows the net effect signatures associated to physical
activity for a specific subject. For illustration purpose,
we chose a subject having a regular physical activity
and no extended period of missing CGM data. The net
effect signatures have been collected for a period of 20
consecutive days. These net effect signatures can be used
in a control algorithm to predict the effect of physical
activity and to improve the safety of glucose regulation
(Patek (2010)).
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Fig. 4. Example of net effect for a 32-hour period.
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Fig. 5. Net effect signatures associated to physical activity
for a specific subject. The net effect signatures have
been collected for a period of 20 consecutive days.
6. CONCLUSION
This paper presents a method based on mathematical
deconvolution to quantify the glucose variations that are
not represented in a model. By combining this with a
watch tracking physical activity, we are able to isolate
the glucose variations associated to physical activity. One
of the limitations of this study is that physical activity
is often preceded by a meal intake and/or an insulin
bolus, thus making it difficult to distinguish between the
variations in glucose concentration due to physical activity
and the variations in glucose concentration due to meal
and/or insulin bolus.
However, the fact that physical activity is usually coupled
with a meal intake and/or an insulin bolus is still useful
to predict the glucose variations during and after exercise.
Moreover, meals, insulin delivery, sensor drifts etc. limit
our ability to evaluate the long-lasting effects of exercise
through net effect.
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6. CONCLUSION
This paper presents a method based on mathematical
deconvolution to quantify the glucose variations that are
not represented in a model. By combining this with a
watch tracking physical activity, we are able to isolate
the glucose variations associated to physical activity. One
of the limitations of this study is that physical activity
is often preceded by a meal intake and/or an insulin
bolus, thus making it difficult to distinguish between the
variations in glucose concentration due to physical activity
and the variations in glucose concentration due to meal
and/or insulin bolus.
However, the fact that physical activity is usually coupled
with a meal intake and/or an insulin bolus is still useful
to predict the glucose variations during and after exercise.
Moreover, meals, insulin delivery, sensor drifts etc. limit
our ability to evaluate the long-lasting effects of exercise
through net effect.
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